Cancer

As genetic screening becomes routine for cancer detection and treatment, we need to ensure this can be delivered at scale and quickly within a national health system. Here, Don White takes us through this challenge and looks at the success of CRUK’s Stratified Medicine Programme 2… It’s clear genomics will be at the heart of
0 Comments
Bob Riter I’d like to give myself a magic wand at this time of the year to grant wishes to those affected by cancer. This was a wish list I put together in 2015, yet it is still relevant. Maybe this will be the year my wishes come true! Here are my wishes for the
0 Comments
This year we have seen three different Prime Ministers and UK governments. Amongst the political turbulence, we’ve accomplished a lot in cancer policy and campaigning in all four nations of the UK and globally. From research and prevention to diagnosis, we’ve been advocating for change to beat cancer. Here are some highlights. A group of
0 Comments
This year, we’ve been celebrating our 20th anniversary. And as part of that, we’re looking back at the influence and involvement we’ve had in reducing cancer death rates. Since we were founded in February 2002, we’ve invested £5.4 billion into life-changing research. And that’s translated into some incredible results. Overall, cancer death rates have decreased
0 Comments
The path to policy change is rarely straightforward. The UK Government’s decision last week to further delay (until October 2025) implementing legislation to restrict junk food advertising on TV and online is just the most recent example. That doesn’t stop this particular setback hurting – as it slows down vital progress towards reducing the number
0 Comments
The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects. Here we explore how the partnership is enabling one researcher’s career long mission to better the lives of childhood brain cancer patients… The course of Richard Gilbertson’s career was
0 Comments
The holidays can be very stressful – particularly when you are already dealing with a cancer diagnosis or are the caregiver for someone with cancer.  Perhaps you know someone in such a situation. Whether they are a family member, good friend, or just the woman down the street you always pass when walking the dog,
0 Comments
Our 20th anniversary year has been about much more than looking back. 2022 has been full of research and advances that are worth celebrating in themselves.  Read on to find out what our scientists have been working on this year, and to learn more about the people that make their discoveries possible. A tumour model
0 Comments
Michelle Mitchell, chief executive of Cancer Research UK Michelle Mitchell, chief executive of Cancer Research UK Flashback to February 4th, the start of Cancer Research UK’s 20th anniversary year. The then Secretary of State for Health and Social Care, Sajid Javid, declared a ‘War on Cancer’, committing to publish a 10-year plan, which promised to
0 Comments
Loren (left) and Dinny (right), who both lost their voices during their cancer treatment Human beings face many of their worst demons by expressing their emotions and sharing their experiences with others. For most patients, speaking out about a cancer diagnosis and voicing worries, fears, highs and lows, is an important way of dealing with
0 Comments
CRUK and UICC’s Tobacco Control Partnership in Kenya and Uganda is launched at the World Cancer Congress “Since the last World Cancer Congress in 2018, more than 25 million people have died from cancer. Around the world, the COVID-19 pandemic caused significant disruptions to services to prevent cancer and detect and treat it early. We
0 Comments
United Nations Climate Change Conference (COP26) In November 2021, Cancer Research UK Chief Clinician, Professor Charles Swanton, visited our longstanding corporate partner ScottishPower at their headquarters in Glasgow. He was there during the United Nations Climate Change Conference (COP26) to deliver the keynote speech at their ‘Air Pollution and Cancer’ event. This marked the start
0 Comments
We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs. Kairbaan Hodivala-Dilke is the new Chair of our Research Careers Committee. Her research group investigates the molecular mechanisms underlying stromal contributions to tumour growth and therapy efficacy. Simon Boulton is Principal Group Leader of
0 Comments